Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Nicholas A. Kennedy, James R. Goodhand, Claire Bewshea, Rachel Nice, Desmond Chee, Simeng Lin, Neil Chanchlani, Jeffrey Butterworth, Rachel Cooney, Nicholas M. Croft, Ailsa L. Hart, Peter M. Irving, Klaartje B. Kok, Christopher A. Lamb, Jimmy K. Limdi, Jonathan MacDonald, Dermot P. B. McGovern, Shameer J. Mehta, Charles D. Murray, Kamal V. PatelRichard C. G. Pollok, Timothy Raine, Richard K. Russell, Christian P. Selinger, Philip J. Smith, Jack Bowden, Timothy J. McDonald, Charlie W. Lees, Shaji Sebastian, Nicholas Powell, Tariq Ahmad (Lead / Corresponding author), , Craig Mowat (Contributing member)
Dive into the research topics of 'Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab'. Together they form a unique fingerprint.